| Literature DB >> 23544021 |
G Barbanti Bròdano1, F Lolli, K Martikos, A Gasbarrini, S Bandiera, T Greggi, P Parisini, S Boriani.
Abstract
STUDYEntities:
Year: 2010 PMID: 23544021 PMCID: PMC3609004 DOI: 10.1055/s-0028-1100890
Source DB: PubMed Journal: Evid Based Spine Care J ISSN: 1663-7976
Fig. 2Posterior lumbar interbody fusion for low grade isthmic spondylolisthesis, 3 and 15 months after surgery. Note the segmental sagittal alignement (kyphosis) that could compromise long term clinical and radiographic outcome (risk of negative effect on adjacent disc).
Fig. 3CT scan 15 months after surgery.
Fig. 4Posterolateral fusion for low grade isthmic spondylolisthesis. Note the postoperative disc height gain that could compromise fusion.
Fig. 1Patient sampling and selection
Characteristics of intervention groups
| PLIF group | PLF group | |||
|---|---|---|---|---|
| All enrolled | Patients at follow-up | All enrolled | Patients at follow-up | |
| Age, years (mean ±SD) | 54.8 ±8.6 | 55.1 ±9.2 | 51.6 ±8.6 | 49.3 ±7.4 |
| n (%) | n (%) | n (%) | n (%) | |
| Female gender | 25 (53.2) | 14 (50.0) | 39 (58.2) | 24 (55.8) |
| Spondylolisthesis grade I | 21 (44.7) | 12 (42.9) | 28 (41.8) | 16 (37.2) |
| Spondylolisthesis grade II | 26 (55.3) | 16 (57.1) | 39 (58.2) | 28 (65.1) |
| L3–4 spondylolisthesis | 3 (6.4) | 2 (7.1) | 0 (0) | 0 (0) |
| L4–5 spondylolisthesis | 16 (34.0) | 14 (50.0) | 25 (37.3) | 14 (32.6) |
| L5–S1 spondylolisthesis | 28 (59.6) | 12 (42.9) | 42 (62.7) | 29 (67.4) |
| 1 level fusion | 30 (63.8) | 19 (67.9) | 50 (74.6) | 32 (74.4) |
| 2 level fusion | 13 (27.7) | 7 (25.0) | 16 (23.9) | 11 (25.6) |
| 3 or more level fusion | 4 (8.5) | 2 (7.1) | 1 (1.5) | 0 (0) |
Clinical outcome
| PLIF group | PLF group | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Percent change | Within group | Baseline | Follow-up | Percent change | Within group | Between group | ||
| ODI (mean % ±SD) | 53.2 ± 18.8 | 25.6 ± 18.1 | 57.7 ± 24.4 | <.05 | 52.1 + 19.0 | 24.5 + 18.3 | 59.2 + 24.9 | <.05 | >.05 | |
| RMDQ | 13.9 ± 6.1 | 7.2 ± 6.2 | 57.3 ± 26.5 | <.05 | 13.4 ± 6.2 | 6.9 ± 6.3 | 58.3 ± 27.4 | <.05 | >.05 | |
| VAS “leg score” | 7.4 ± 1.4 | 4.1 ± 2.8 | 49.3 ± 30.0 | <.05 | 7.6 ± 1.4 | 3.5 ± 3.2 | 58.5 ± 33.6 | <.05 | >.05 | |
| VAS “back score” | 7.7 ± 1.3 | 3.0 ± 2.0 | 62.8 ± 21.8 | <.05 | 7.8 ± 1.3 | 3.8 ± 2.7 | 55.3 ± 29.1 | <.05 | >.05 | |
| Persistent low-back pain (%) | 100% | 14.3% | n.a. | n.a. | 100% | 18.6% | n.a. | n.a. | n.a. | |
| Persistent sciatica | 100% | 3.6% | n.a. | n.a. | 100% | 11.6% | n.a. | n.a. | n.a. | |
P-value associated with change from baseline to follow-up in each treatment group
P-value comparing change in baseline to follow-up between PLIF and PLF groups
Major complications requiring revision surgery
| PLIF group | PLF group | |
|---|---|---|
| Major complications, n (%) | ||
| Revision surgery | 1 (3.6) | 4 (9.3) |
| Pseudarthrosis | 1 (3.6) | 2 (4.6) |
Revision due to pseudarthrosis
Two revisions due to pseudarthrosis